When comparing our findings to a study investigating the relationship between insulin treatment and the risk of major adverse cardiovascular events (MACE) in stable type 2 diabetes patients, (Schwartz et al., 2016) especially those with recent acute coronary syndrome (ACS). The gene discussed is INS; the disease is acute coronary syndrome.